Tepadina And Sodium Chloride is a drug owned by Adienne Sa. It is protected by 1 US drug patent filed in 2025 out of which none have expired yet. Based on its patents and exclusivities, its generic launch date is estimated to be May 31, 2037. Details of Tepadina And Sodium Chloride's patents and their expiration are given in the table below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| These drug patents focus on the other aspects of the drug like dosage, mode of administration (oral, tablet, capsules, liquids etc). | |||
| US9931458 | Multi chamber flexible bag and methods of using same |
May, 2037
(11 years from now) | Active |
US patents provide insights into the exclusivity only within the United States, but Tepadina And Sodium Chloride is protected by patents in multiple countries. Understanding the full scope of patent protection is crucial in strategizing market entry. By looking at the broader patent landscape, you can identify markets with weaker patent protection which could be ideal generic entry points. The following section offers details on Tepadina And Sodium Chloride's family patents as well as insights into ongoing legal events on those patents.
Tepadina And Sodium Chloride's Family Patents
Explore Our Curated Drug Screens
Generic Launch
Generic Release Date:
Tepadina And Sodium Chloride's generic launch date based on the expiry of its last outstanding patent is estimated to be May 31, 2037 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)
Tepadina And Sodium Chloride Generic API suppliers:
Thiotepa is the generic name for the brand Tepadina And Sodium Chloride. 11 different companies have already filed for the generic of Tepadina And Sodium Chloride, with Meitheal having the maximum number of approved applications. Check out the entire list of companies who have already received approval for Tepadina And Sodium Chloride's generic
Alternative Brands for Tepadina And Sodium Chloride
There are several other brand drugs using the same active ingredient (Thiotepa) as Tepadina And Sodium Chloride. Given below is the list of those companies and their brand drugs, to help you identify new opportunities, assess competitors, and plan your market strategies more effectively.
| Drug Owner | Drug Name | |
|---|---|---|
| Shorla |
|
Apart from brand drugs containing the same ingredient, some generics have also been filed for Thiotepa, Tepadina And Sodium Chloride's active ingredient. Check the complete list of approved generic manufacturers for Tepadina And Sodium Chloride
About Tepadina And Sodium Chloride
Tepadina And Sodium Chloride is a drug owned by Adienne Sa. Tepadina And Sodium Chloride uses Thiotepa as an active ingredient. Tepadina And Sodium Chloride was launched by Adienne Sa in 2017.
Approval Date:
Tepadina And Sodium Chloride was approved by FDA for market use on 26 January, 2017.
Active Ingredient:
Tepadina And Sodium Chloride uses Thiotepa as the active ingredient. Check out other Drugs and Companies using Thiotepa ingredient
Dosage:
Tepadina And Sodium Chloride is available in powder form for intravenous use. Given below is detailed information on Dosage -
| Strength | Dosage Form | Availability | Application Pathway |
|---|---|---|---|
| 200MG | POWDER | Prescription | INTRAVENOUS |